92
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies

, , , ORCID Icon, ORCID Icon, , , ORCID Icon, , , , & show all
Pages 125-130 | Published online: 13 Nov 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (2)